Invasive species drive polymicrobial resistance to amoxicillin in oral biofilms through β-lactamase release

This article has 0 evaluations Published on
Read the full article Related papers
This article on Sciety

Abstract

Since bacterial biofilms often cause refractory infections, antimicrobial susceptibility testing (AST) is highly desirable even for oral peri-implant biofilms. However, characterization of polymicrobial drug resistance is challenging due to high diversity and complexity of these biofilms. In this work, we developed laser-assisted AST and detected polymicrobial amoxicillin resistance in peri-implantitis. TEM-1 β-lactamase production enabled anEnterobactersp. strain SPS_532 to protect its otherwise susceptible biofilm cohabitants. To understand the β-lactamase driven cross-protection in the human microbiome we aggregated genomic (n = 200,000) and patient microbial data (n = 27,000), developed a cross-protection assay, studied a representative strain collection (n = 118) and established a complex biofilmin vitromodel (with an average of 133 species from 164 found in dental plaque). Multiple oral allochthonous species,e.g.,Enterobacter,Klebsiella,Escherichia,Staphylococcus, and only a single typical oral microorganism,Haemophilus, were able to cross-protect. Diverseblagenes conferred activity, via a high expression of chromosomal gene,e.g.,blaAmpCgene or by the presence of plasmidic gene,e.g., blaTEM-1gene. Invaders not only cross-protected the biofilm from the antibiotic, but also supported expansion of opportunistic pathogens likeFusobacteriumspecies. Cross-protection in complex biofilms depended on the diffusion rate and population size of the invader, which could be bio-controlled with a phage. Deciphering polymicrobial resistance might support the development of diagnostic and therapeutic approaches to combat implant-associated biofilm infections in the human mouth.

Related articles

Related articles are currently not available for this article.